MiR-149 inhibits non-small-cell lung cancer cells EMT by targeting FOXM1

Biochemistry Research International

Volumn , Issue , 2013, Pages

  Ke, Yang ^a   Zhao, Weiyong ^b   Xiong, Jie ^a   Cao, Rubo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE SECOND AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84878650763     PISSN: 20902247     EISSN: 20902255     Source Type: Journal    
DOI: 10.1155/2013/506731     Document Type: Article

References (28)

1. Gao D., Vahdat L. T., Wong S., Chang J. C., Mittal V., Microenvironmental regulation of epithelial-mesenchymal transitions in cancer. Cancer Research 2012 72 19 4883 4889 10.1158/0008-5472.CAN-12-1223
2. Kim M. A., Lee H. S., Lee H. E., Kim J. H., Yang H. K., Kim W. H., Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma. Histopathology 2009 54 4 442 451 2-s2.0-62149103291 10.1111/j.1365-2559.2009.03247.x
3. Nagathihalli N. S., Merchant N. B., Src-mediated regulation of E-cadherin and EMT in pancreatic cancer. Frontiers in Bioscience 2012 17 2059 2069
4. Fuxe J., Karlsson M. C., TGF-beta-induced epithelial-mesenchymal transition: a link between cancer and inflammation. Seminars in Cancer Biology 2012 22 455 461
5. Mallick R., Patnaik S., Yendamuri S., MicroRNAs and lung cancer: biology and applications in diagnosis and prognosis. Journal of Carcinogenesis 2010 9, article no. 8 2-s2.0-77956579573 10.4103/1477-3163.67074
6. Zaninovic V., Zamora T., Tajima K., Origins of T-cell leukaemia virus. Nature 1990 344 6264 299 2-s2.0-0025269641 (Pubitemid 20112292)
7. Pan S. J., Zhan S. K., Pei B. G., Sun Q. F., Bian L. G., Sun B. M., MicroRNA-149 inhibits proliferation and invasion of glioma cells via blockade of AKT1 signaling. International Journal of Immunopathology and Pharmacology 2012 25 871 881
8. Koshiol J., Rotunno M., Consonni D., Pesatori A. C., De Matteis S., Goldstein A. M., Chaturvedi A. K., Wacholder S., Landi M. T., Lubin J. H., Caporaso N. E., Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study. PLoS ONE 2009 4 10 2-s2.0-70350223450 10.1371/journal.pone.0007380 e7380
9. Angulo M., Lecuona E., Sznajder J. I., Role of MicroRNAs in lung disease. Archivos de Bronconeumología 2012 48 325 330
10. Gupta G. P., Massagué J., Cancer Metastasis: building a Framework. Cell 2006 127 4 679 695 2-s2.0-33751252276 10.1016/j.cell.2006.11.001 (Pubitemid 44781029)
11. Lin P. Y., Yu S. L., Yang P. C., MicroRNA in lung cancer. British Journal of Cancer 2010 103 8 1144 1148 2-s2.0-77957982985 10.1038/sj.bjc.6605901
12. Solomides C. C., Evans B. J., Navenot J. M., Vadigepalli R., Peiper S. C., Wang Z. X., MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis. Acta Cytologica 2012 56 645 654
13. Zhang Y. K., Zhu W. Y., He J. Y., miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes. Journal of Cancer Research and Clinical Oncology 2012 138 10 1641 1650
14. He L., Thomson J. M., Hemann M. T., Hernando-Monge E., Mu D., Goodson S., Powers S., Cordon-Cardo C., Lowe S. W., Hannon G. J., Hammond S. M., A microRNA polycistron as a potential human oncogene. Nature 2005 435 7043 828 833 2-s2.0-20444467290 10.1038/nature03552 (Pubitemid 40839734)
15. Cao M., Seike M., Soeno C., MiR-23a regulates TGF- β -induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells. International Journal of Oncology 2012 41 13 869 875 10.3892/ijo.2012.1535
16. Liu X., Sempere L. F., Ouyang H., Memoli V. A., Andrew A. S., Luo Y., Demidenko E., Korc M., Shi W., Preis M., Dragnev K. H., Li H., Direnzo J., Bak M., Freemantle S. J., Kauppinen S., Dmitrovsky E., MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. Journal of Clinical Investigation 2010 120 4 1298 1309 2-s2.0-77951154173 10.1172/JCI39566
17. Brabletz S., Brabletz T., The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer? EMBO Reports 2010 11 9 670 677 2-s2.0-77956230322 10.1038/embor.2010.117
18. Li J., Wang Y., Luo J., miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells. FEBS Letters 2012 586 20 3761 3765 10.1016/j.febslet.2012.09.016
19. Zhang J., Liu Y. F., Gan Y., Lack of association between miR-149 C > T polymorphism and cancer susceptibility: a meta-analysis based on 4,677 cases and 4,830 controls. Molecular Biology Reports 2012 39 9 8749 8753 10.1007/s11033-012-1735-4
20. Wang Y., Zheng X., Zhang Z., MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer. PLoS ONE 2012 7 e41693 10.1371/journal.pone.0041693
21. Li D., Chen P., Li X. Y., Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas. OMICS 2011 15 10 673 682 10.1089/omi.2011.0064
22. Jin L., Hu W. L., Jiang C. C., MicroRNA-149 a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proceedings of the National Academy of Sciences of the United States of America 2011 108 38 15840 15845 10.1073/pnas.1019312108
23. Luo Z., Zhang L., Li Z., An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC Medical Genomics 2012 5 3 10.1186/1755-8794-5-3
24. Wang Y., Wen L., Zhao S. H., Ai Z. H., Guo J. Z., Liu W. C., FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients. Lung Cancer 2013 79 173 179
25. Hui M. K., Chan K. W., Luk J. M., Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage. World Journal of Surgery 2012 36 1 90 97 10.1007/s00268-011-1302- 5
26. Millour J., Constantinidou D., Stavropoulou A. V., Wilson M. S. C., Myatt S. S., Kwok J. M. M., Sivanandan K., Coombes R. C., Medema R. H., Hartman J., Lykkesfeldt A. E., Lam E. W. F., FOXM1 is a transcriptional target of ER α and has a critical role in breast cancer endocrine sensitivity and resistance. Oncogene 2010 29 20 2983 2995 2-s2.0-77952675958 10.1038/onc.2010.47
27. Koo C. Y., Muir K. W., Lam E. W., FOXM1: from cancer initiation to progression and treatment. Biochimica et Biophysica Acta 2012 1819 28 37
28. Priller M., Pöschl J., Abrão L., Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients. Clinical Cancer Research 2011 17 21 6791 6801 10.1158/1078-0432.CCR-11-1214